expert report on neoadjuvant immune checkpoint inhibitors for nsclc
Published 2 years ago • 1.2K plays • Length 7:00Download video MP4
Download video MP3
Similar videos
-
4:58
expert report on neoadjuvant immune checkpoint inhibitors for melanoma
-
5:30
expert report on immune checkpoint inhibitors for dmmr colorectal cancer
-
31:50
current & future considerations for the use of immune checkpoint inhibitors in nsclc
-
3:44
aacr 2023 highlights on advances in the neoadjuvant treatment of resectable nsclc with john heymach
-
40:21
extending horizons with immune checkpoint inhibitors in small cell lung cancer: 2022 perspectives
-
1:36
nadina trial: neoadjuvant ipilimumab nivolumab vs. adjuvant nivolumab in stage iii melanoma
-
5:02
肠癌的治疗方法有哪些? 纽约肿瘤科专家蒋威廉医生为您讲解
-
12:12
single or dual agent io/chemotherapy for pd-l1 negative nsclc
-
17:49
the niche-2 study discussion - oncbrothers (rohit and rahul gosain) with dr. myriam chalabi
-
3:47
adjuvant pembrolizumab, durvalumab, and more considerations from uc trials presented at esmo 2024
-
7:29
myriam chalabi, esmo 2022: neoadjuvant immune checkpoint inhibition in mmr-deficient colon cancer
-
0:43
rational for neoadjuvant ici-based therapy in oncogene-driven resectable nsclc
-
2:46
#esmo22 highlights on neoadjuvant ici in locally advanced dmmr colon cancer: the niche-2 study
-
0:54
surgical endpoints are needed in lung cancer trials of neoadjuvant therapy
-
1:07
can we rechallenge immune checkpoint inhibitors (#ici) as second-line treatment for advanced nsclc?
-
7:25
how to manage toxicities from immune checkpoint inhibitors?
-
4:35
neoadjuvant checkpoint inhibition in nsclc
-
1:05
limitations in immune checkpoint inhibitors in treating gastric cancer
-
1:20
resistance to immune checkpoint blockade in patients with cscc
-
3:37
immune checkpoint inhibitor combinations: challenges and future perspectives
-
15:22
neoadjuvant immune checkpoint inhibition for muscle invasive bladder cancer